Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 5579N

GlaxoSmithKline PLC

26 October 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Sir Philip Hampton

Position/status

Non-Executive Chairman

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	2,662.812

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Professor Sir Roy Anderson

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	437.462

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Mr Vindi Banga

Position/status

Senior Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	1,749.848

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Ms Stacey Cartwright

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	323.341

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Dr Vivienne Cox

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	323.341

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Ms Lynn Elsenhans

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
$40.70	1,131.786

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Ms Judy Lewent

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

Acquisition of notional ADSs under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
$40.70	454.112

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

Details of PDMR/person closely associated with them ('PCA')

Name

Mr Urs Rohner

Position/status

Independent Non-Executive Director

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of notional Ordinary Shares under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.43	399.422

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-26

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQQLFLQBFBFBV

RNS metadata

Title: Director/PDMR Shareholding
Time: 18:10:05
Date: 26 Oct 2016
Category: Director/PDMR dealings
ID: 5579N